- Home
- WAL vs LNTH Comparison
WAL vs LNTH Comparison
Compare WAL & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAL
- LNTH
- Stock Information
- Founded
- WAL 1994
- LNTH 1956
- Country
- WAL United States
- LNTH United States
- Employees
- WAL N/A
- LNTH N/A
- Industry
- WAL Major Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WAL Finance
- LNTH Health Care
- Exchange
- WAL Nasdaq
- LNTH Nasdaq
- Market Cap
- WAL 7.8B
- LNTH 7.5B
- IPO Year
- WAL 2005
- LNTH 2015
- Fundamental
- Price
- WAL $71.85
- LNTH $75.13
- Analyst Decision
- WAL Strong Buy
- LNTH Strong Buy
- Analyst Count
- WAL 15
- LNTH 5
- Target Price
- WAL $96.33
- LNTH $133.80
- AVG Volume (30 Days)
- WAL 852.7K
- LNTH 1.5M
- Earning Date
- WAL 07-17-2025
- LNTH 05-07-2025
- Dividend Yield
- WAL 2.11%
- LNTH N/A
- EPS Growth
- WAL 6.13
- LNTH N/A
- EPS
- WAL 7.28
- LNTH 3.53
- Revenue
- WAL $3,049,400,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- WAL $13.26
- LNTH $4.96
- Revenue Next Year
- WAL $9.87
- LNTH $10.25
- P/E Ratio
- WAL $9.88
- LNTH $21.28
- Revenue Growth
- WAL 11.37
- LNTH 12.53
- 52 Week Low
- WAL $56.70
- LNTH $75.00
- 52 Week High
- WAL $98.10
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- WAL 45.33
- LNTH 27.24
- Support Level
- WAL $70.45
- LNTH $77.01
- Resistance Level
- WAL $80.47
- LNTH $81.50
- Average True Range (ATR)
- WAL 2.04
- LNTH 3.52
- MACD
- WAL 0.04
- LNTH -1.61
- Stochastic Oscillator
- WAL 13.28
- LNTH 0.35
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.